Tackling COVID-19: Repurposing of therapeutic antibodies and development of a comprehensive antibody database
COVID-19, caused by a novel coronavirus, SARS-CoV-2 has emerged to be a global pandemic affecting over 33 million people worldwide by the end of September 2020 (https://covid19.who.int/). The pandemic is especially …
